Advertisement
Diseases
Subscribe to Diseases
View Sample

FREE Email Newsletter

FDA weighs unknowns of 3-person embryo technique

February 26, 2014 10:42 am | by Matthew Perrone, AP Health Writer | News | Comments

At a recent two-day meeting, the Food and Drug Administration heard from supporters and opponents of a provocative new technique meant to prevent children from inheriting debilitating diseases. The method creates babies from the DNA of three people, and the agency is considering whether to greenlight testing in women who have defective genes.

Experimental treatment eradicates acute leukemia in mice

February 26, 2014 7:53 am | by Shaun Mason, Univ. of California, Los Angeles | News | Comments

A diverse team of scientists from Univ. of California, Los Angeles' Jonsson Comprehensive Cancer Center has developed an experimental treatment that eradicates an acute type of leukemia in mice without any detectable toxic side effects. The drug works by blocking two important metabolic pathways that the leukemia cells need to grow and spread.

“Bad cholesterol” indicates an amino acid deficiency

February 26, 2014 7:29 am | by Diana Yates, Life Sciences Editor Univ. of Illinois, Urbana-Champaign | News | Comments

Low-density lipoprotein (LDL), the “bad cholesterol” that doctors consider a sign of potential heart disease, is merely a marker of a diet lacking all of the essential amino acids, says Univ. of Illinois comparative biosciences prof. Fred Kummerow, 99, a longtime opponent of the medical establishment’s war on cholesterol.

Advertisement

Polio-like disease appears in California children

February 25, 2014 2:09 am | by Martha Mendoza - AP National Writer - Associated Press | News | Comments

An extremely rare, polio-like disease has appeared in more than a dozen California children within the past year and paralyzed one or more of each child's arms or legs, Stanford Univ. researchers say, but public health officials haven't identified any common causes connecting the cases.

Using viruses as nanoscale building blocks

February 21, 2014 11:28 am | by Mona S. Rowe, Brookhaven National Laboratory | News | Comments

From steel beams to plastic Lego bricks, building blocks come in many materials and all sizes. Today, science has opened the way to manufacturing at the nanoscale with biological materials. Potential applications range from medicine to optoelectronic devices. In a paper published in Soft Matter, scientists announced their discovery of a 2-D crystalline structure assembled from the outer shells of a virus.

Sun powers complex cancer test for remote regions

February 21, 2014 8:19 am | by Blaine Friedlander, Cornell Univ. | News | Comments

From the sun, a solution: Cornell Univ. and Weill Cornell Medical College researchers have remodeled an energy-intensive medical test, designed to detect a deadly skin cancer related to HIV infections, to create a quick diagnostic assay perfect for remote regions of the world. By harnessing the sun’s power and employing a smartphone application, medical technicians may now handily administer reliable assays for Kaposi’s sarcoma.

A changing view of bone marrow cells

February 21, 2014 7:55 am | by Kimm Fesenmaier, Caltech | News | Comments

In the battle against infection, immune cells are the body's offense and defense. It has long been known that a population of blood stem cells that resides in the bone marrow generates all of these immune cells. But most scientists have believed that blood stem cells participate in battles against infection in a delayed way, replenishing immune cells on the front line only after they become depleted.

Flu season waning; younger adults hit hardest

February 20, 2014 2:09 pm | by Mike Stobbe - AP Medical Writer - Associated Press | News | Comments

As the flu season winds down, health officials say it wasn't as bad as last year and the vaccine worked better. But younger adults were hit harder because of a surge of swine flu. Overall, hospitalization rates for the flu are only about half what they were last winter. It has been a fairly mild season for the elderly—usually the most vulnerable group to flu and its complications.

Advertisement

Uncovering the secrets of tularemia

February 18, 2014 8:26 am | by Stephen P Wampler, Lawrence Livermore National Laboratory | News | Comments

Tularemia is endemic in the northeastern U.S., and is considered to be a risk to biosecurity, much like anthrax or smallpox, because it has already been weaponized in various regions of the world. A postdoctoral researcher at Lawrence Livermore National Laboratory has recently described his work to uncover the secrets of the bacterium Francisella tularensis, which causes tularemia, also known as "rabbit fever."

Test could predict which teen boys get depression

February 18, 2014 8:09 am | by Maria Cheng - AP Medical Writer - Associated Press | News | Comments

A saliva test for teenage boys with mild symptoms of depression could help identify those who will later develop major depression, a new study says. Researchers measured the stress hormone cortisol in teenage boys and found that ones with high levels coupled with mild depression symptoms were up to 14 times more likely to suffer clinical depression later in life than those with low or normal cortisol levels.

Hitchhiking vaccines boost immunity

February 18, 2014 8:04 am | by Anne Trafton, MIT News Office | News | Comments

Many vaccines consist of a killed or disabled version of a virus. However, for certain diseases, this type of vaccine is ineffective, or just too risky. An alternative, safer approach is a vaccine made of small fragments of proteins produced by a disease-causing virus or bacterium. This has worked for some diseases, but in many cases these vaccines don’t provoke a strong enough response. Until now.

Research reveals structure of key protein complex

February 13, 2014 1:04 pm | by Veronica Meade-Kelly, Broad Institute | News | Comments

Researchers have formed the first high-definition picture of the Cas9 complex, a key part of the CRISPR-Cas system used by scientists as a genome-editing tool to silence genes and probe the biology of cells. Their findingsare expected to help researchers refine and further engineer the tool to accelerate genomic research and bring the technology closer to use in the treatment of human genetic disease.

U.S., 26 countries launch effort to fight disease outbreaks

February 13, 2014 12:09 pm | by Lauran Neergaard - AP Medical Writer - Associated Press | News | Comments

The U.S. and 26 other countries began a new effort Thursday to prevent and fight outbreaks of dangerous infectious diseases before they spread around the globe. U.S. health officials called the Global Health Security Agenda a priority because too many countries lack the health infrastructure necessary to spot a new infection rapidly and sound the alarm before it has time to gain a foothold and even spread into other countries.

Advertisement

How chronic stress leads to mental illness

February 12, 2014 8:05 am | by Robert Sanders, UC Berkeley Media Relations | News | Comments

Univ. of California, Berkeley researchers have shown that chronic stress generates long-term changes in the brain that may explain why people suffering chronic stress are prone to mental problems such as anxiety and mood disorders later in life. Their findings could lead to new therapies to reduce the risk of developing mental illness after stressful events.

Panel votes down heart safety claim for naproxen

February 11, 2014 2:09 pm | by Matthew Perrone - AP Health Writer - Associated Press | News | Comments

A majority of federal health experts said Tuesday that new research is not strong enough to conclude that naproxen, the pain reliever in Aleve and many other medications, is safer on the heart than rival drugs used by millions of Americans to treat arthritis and everyday aches and pains. The Food and Drug Administration advisory panel voted against the conclusion that naproxen has a lower risk of heart attack than ibuprofen.

FDA reconsiders heart safety of common pain pills

February 10, 2014 1:08 pm | by Matthew Perrone - AP Health Writer - Associated Press | News | Comments

Federal health experts are taking a second look this week at the heart safety of pain medications used by millions of Americans to treat arthritis and other everyday aches and pains. The Food and Drug Administration holds a two-day meeting beginning Monday to examine the latest research on anti-inflammatory medicines called NSAIDS, which serve as the backbone of U.S. pain treatment.

More Hope for a HIV-1 Vaccine

February 10, 2014 9:15 am | by Lindsay Hock, Managing Editor | Articles | Comments

On the eve of the 25th World AIDS Day (December 2014), President Barack Obama expressed hope to our nation, proclaiming that an “AIDS-free generation is within our reach.” During his speech, Obama expressed how our nation has made significant strides toward strengthening scientific investments, building effective HIV/AIDS education and prevention programs and bringing together public and private stakeholders.

Method for delivering HIV-fighting antibodies proven promising

February 10, 2014 8:32 am | by Kimm Fesenmaier, Caltech | News | Comments

In 2011, biologists at Caltech demonstrated a highly effective method for delivering HIV-fighting antibodies to mice—a treatment that protected the mice from infection by a laboratory strain of HIV delivered intravenously. Now the researchers have shown that the same procedure is just as effective against a strain of HIV found in the real world, even when transmitted across mucosal surfaces.

Targeted Healing of the Immune System

February 9, 2014 10:00 am | by Lindsay Hock, Managing Editor | Articles | Comments

In the U.S. about 12,500 women are diagnosed with cervical cancer a year. Out of these women, about 4,500 progress into invasive cervical cancer or the end stage of the disease. This leaves about 8,000 women a year in the U.S. that are cured through existing standard of care treatment: surgery or chemotherapy/radiation. However, chemotherapy/radiation have terrible side effects in some cases.

Doctor diagnoses man with help from TV's "House"

February 7, 2014 11:08 am | by Maria Cheng - AP Medical Writer - Associated Press | News | Comments

If you're unlucky enough to be stricken with a rare medical condition, you'd better hope your doctor watches the right television show. That was the lesson for one German man with severe heart failure and a puzzling mix of symptoms including fever, blindness, deafness and enlarged lymph nodes, which baffled doctors for months.

First guidelines issued to prevent stroke in women

February 6, 2014 4:09 pm | by Marilynn Marchione - AP Chief Medical Writer - Associated Press | News | Comments

Just as heart attack symptoms may differ between men and women, so do stroke risks. Now, the American Heart Association has issued its first guidelines for preventing strokes in women. They focus on birth control, pregnancy, depression and other risk factors that women face uniquely or more frequently than men do.

Pinpointing the brain’s arbitrator

February 6, 2014 8:30 am | by Kimm Fesenmaier, Caltech | News | Comments

We tend to be creatures of habit. In fact, the human brain has a learning system devoted to guiding us through routine, or habitual, behaviors. At the same time, the brain has a separate goal-directed system for the actions we undertake only after careful consideration of the consequences. We switch between the two systems as needed. But how does the brain know which system to give control to at any given moment? Enter The Arbitrator.

NIH, drugmakers, foundations partner to find meds

February 4, 2014 1:09 pm | by Linda A. Johnson - AP Business Writer - Associated Press | News | Comments

The U.S. National Institutes of Health and numerous biopharmaceutical companies and disease foundations have teamed up on an unusual project to find and bring new medicines to patients faster. The Accelerating Medicines Partnership, announced Tuesday, will focus on the early part of drug research.

How a shape-shifting DNA-repair machine fights cancer

February 4, 2014 10:44 am | by Dan Krotz, Lawrence Berkeley National Laboratory | News | Comments

Maybe you’ve seen the movies or played with toy Transformers, those shape-shifting machines that morph in response to whatever challenge they face. It turns out that DNA-repair machines in your cells use a similar approach to fight cancer and other diseases, according to research led by scientists from Lawrence Berkeley National Laboratory.

A quicker, cheaper way to detect staph in the body

February 3, 2014 8:36 am | News | Comments

Chances are you won’t know you’ve got a staph infection until the test results come in, days after the symptoms first appear. But what if your physician could identify the infection much more quickly and without having to take a biopsy and ship it off for analysis? Researchers at the Univ. of Iowa may have found a way.

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading